Abstract

The skin faces the greatest exposure to environmental agents which contribute to the skin’s susceptibility to developing acute and chronic inflammation. NFκB and its upstream modulators, regulate many inflammatory mediators that contribute to inflammation. In the present study, we examined the anti-inflammatory properties of two P-gp substrates that are inhibitors of IêB kinase (IKK), ACHP and IKK 16, and evaluated their potential as topical anti-inflammatory drugs through inhibition of NFκB signaling. P-gp, or MDR1, is expressed in human and mouse skin, and we hypothesized that P-gp substrates would make good candidates for transdermal delivery of topically-applied drugs because P-gp can facilitate their absorptive transport into the systemic circulation. An Pgp-mediated efflux assay revealed both IKK 16 and ACHP were high affinity P-gp substrates/inhibitors, and IKK 16 and ACHP completely blocked nuclear translocation of NFκB in human and murine keratinocytes challenged with IL-1a. Pretreating primary keratinocytes with IKK 16 or ACHP blocked cytokine gene expression induced by IL-1a, TNFa, and PMA in a dose-dependent manner. This indicated that both drugs block the inflammatory signaling pathway downstream of NFκB activation in vitro. However, in vivo studies showed topical ACHP treatment, but not IKK 16, blocked PMA induced cytokine expression in K5-PKCa mice, a mouse skin inflammation model. Further studies revealed that the topical application of ACHP reduced both skin inflammation induced by Imiquimod and tumor formation in DMBA initiated and PMA promoted K5-PKCa mice. In this model ACHP application was not effective at eliminating established tumors. Pretreatment of ACHP also attenuated cytokine expression induced by UV irradiation of FVB mice. These data indicate that ACHP is a potential candidate for a topical drug used for treating skin inflammation that is mediated by NFκB signaling.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.